Dave Ricks

Dave Ricks

Up next

Raj Subramaniam

FedEx President and CEO Raj Subramaniam discusses how the company moves nearly $2 trillion worth of goods annually, its use of AI and data analytics, autonomous trucking, and the massive transformation underway inside FedEx. He also shares his personal journey from Kerala, India ...  Show more

Charlie Scharf

Wells Fargo Chairman and CEO Charlie Scharf says the independence of the Federal Reserve is "critically important" to the the US financial system, even as presidents weigh in on policy. In this wide-ranging interview, Scharf discusses the state of US economy amid tensions with Ir ...  Show more

Recommended Episodes

Eli Lilly CEO Dave Ricks Talks Fighting Obesity, Developing New Drugs
Bloomberg Talks

Eli Lilly CEO Dave Ricks says the company is working on expanding its medicine supply as the global obesity rate increases. Speaking with Bloomberg's Caroline Hyde at the Economic Club of New York, the head of the pharma giant says that they are looking to create an oral tablet i ...  Show more

Eli Lilly CEO: The Weight-Loss Drug Revolution, AI in Pharma, and Innovation
In Good Company with Nicolai Tangen

Nicolai Tangen meets with David Ricks, CEO of Eli Lilly, for a discussion about the pharmaceutical giant's remarkable journey. At the forefront is Eli Lilly's breakthrough work with weight reduction drugs, which are showing promise far beyond their original ...

  Show more

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
All-In with Chamath, Jason, Sacks & Friedberg

(0:00) Introducing Eli Lilly CEO Dave Ricks

(1:43) How Eli Lilly discovered the GLP-1 impact on weight loss, counterfeit products from China

(7:08) GLP-1 pricing and capital allocation after a breakout pharma product

(12:56) Why Biotech VC has plummeted, " ...

  Show more

Market Rally Aims for “Cloud Nine,” Bronfman's Paramount Bid, Eli Lilly CEO on Weight-Loss Drug 8/20/24
Squawk on the Street

Carl Quintanilla and Jim Cramer led off the show by delving into the broadening market rally, as the S&P 500 and Nasdaq aim for a ninth consecutive day of gains. David Faber called into the show with reporting on Edgar Bronfman's bid to acquire Paramount Global. Eli Lilly CEO ...

  Show more